Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test

A variety of commercially available urinary molecular markers have been introduced for detecting and monitoring urothelial carcinoma (UC). We prospectively evaluated the UroVysion(TM) Bladder Cancer Kit (FISH) and the Xpert® Bladder Cancer Detection (Xpert) test. Both tests were performed on voided...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavcic, Niko, Peric, Ivan, Zagorac, Andreja, Kokalj Vokac, Nadja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208547/
https://www.ncbi.nlm.nih.gov/pubmed/35734425
http://dx.doi.org/10.3389/fgene.2022.839598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208547/
https://www.ncbi.nlm.nih.gov/pubmed/35734425
http://dx.doi.org/10.3389/fgene.2022.839598

Ejemplares similares